Originally published on Thu October 4, 2012 7:53 am
The 2010 health law removes one of the big barriers to contraception for many young women: cost. But if they don't feel confident that the care they will receive is confidential, these women may not take advantage of it.
Beau Gunderson's fascinated by what he might learn from his DNA.
"I'm curious about what makes me tick, essentially," says Gunderson, 29, who writes code for a Silicon Valley startup.
So Gunderson has signed up for every genetic test he's been able to afford. And he can't wait for the price of getting his entire genetic code — his genome — to drop to about $1,000, as many are predicting is imminent.
"Yeah, if the price does drop — to a thousand bucks for example — I might pay that. That's a good personal price point for me," Gunderson said.
Originally published on Mon October 1, 2012 3:10 pm
When there's something really wrong with a published study, the journal can retract it, much like a carmaker recalling a flawed automobile.
But are the errors that lead to retractions honest mistakes or something more problematic?
A newly published analysis finds that more than two-thirds of biomedical papers retracted over the past four decades were the result of misconduct, not error. That's much higher than previous studies of retractions had found.
Starting today, America's hospitals will find that their checks from Medicare are a little bit lighter.
As part of the government's biggest effort yet at paying for performance, Medicare is withholding 1 percent of its regular hospital payments and putting that money into a fund to reward hospitals that score well on 20 different quality measures.